Drugmaker Regeneron Pharmaceuticals has announced plans to acquire 23andMe Holding for $256 million through a bankruptcy auction. The purchase, set to conclude in the third quarter of the year, comes
Drugmaker Regeneron Pharmaceuticals has announced plans to acquire 23andMe Holding for $256 million through a bankruptcy auction. The purchase, set to conclude in the third quarter of the year, comes






